Exciplex308nm

K171702 · Clarteis · FTC · Oct 13, 2017 · General, Plastic Surgery

Device Facts

• Record ID: K171702
• Device Name: Exciplex308nm
• Applicant: Clarteis
• Product Code: FTC · General, Plastic Surgery
• Decision Date: Oct 13, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4630
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Exciplex308nm is intended to be used for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.

Device Story

Exciplex308nm is a compact handheld excimer device emitting narrow-band 308nm UVB light. Used by clinicians to treat dermatological conditions; device delivers light via 5x5cm² output window at 100mW/cm² irradiance. Operator applies output window directly to affected skin areas, utilizing treatment tips or silicone masks to shield surrounding healthy tissue. Treatment involves series of light 'shots' across affected area. Device provides targeted phototherapy, potentially benefiting patients by managing skin lesions and pigment disorders through controlled UV exposure.

Clinical Evidence

No clinical data provided. Substantial equivalence established via bench testing, including software verification (IEC 62304), electromagnetic compatibility/electrical safety (IEC 60601-1, IEC 60601-1-2, IEC 60601-2-57), and performance/usability testing (IEC 62471, IEC 62366-1, IEC 60601-1-6).

Technological Characteristics

Handheld excimer lamp; 308nm narrow-band UVB output; 5x5cm² window; 100mW/cm² irradiance. Compliance with IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC), IEC 60601-2-57 (light source safety), and IEC 62471 (photobiological safety). Includes silicone masks/tips for skin shielding.

Indications for Use

Indicated for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma in patients requiring phototherapy.

Regulatory Classification

Identification

An ultraviolet lamp for dermatologic disorders is a device (including a fixture) intended to provide ultraviolet radiation of the body to photoactivate a drug in the treatment of a dermatologic disorder if the labeling of the drug intended for use with the device bears adequate directions for the device's use with that drug.

Predicate Devices

• Model 308 Dermatological Excimer System / Quantel Medical, Inc. (K073066)
• GME ExSys 308 / GME German Medical Engineering GmbH (K150752)
• VTRAC Excimer Lamp System / PhotoMedex, Inc. (K051428)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

October 13, 2017 Clarteis % Allison Komiyama, Ph.D., RAC AcKnowledge Regulatory Strategies, LLC 2834 Hawthorn St. San Diego, California 92104

Re: K171702

Trade/Device Name: Exciplex308nm Regulation Number: 21 CFR 878.4630 Regulation Name: Ultraviolet lamp for dermatologic disorders Regulatory Class: Class II Product Code: FTC, GEX Dated: September 18, 2017 Received: September 19, 2017

Dear Dr. Komiyama:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

# Jennifer R. Stevenson -S3

For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K171702

Device Name Exciplex308nm

Indications for Use (Describe)

The Exciplex308nm is intended to be used for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

#### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

#### FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Clarteis

# 510(k) Summary K171702

#### DATE PREPARED

October 13, 2017

#### MANUFACTURER AND 510(k) OWNER

Clarteis, SAS WTC2, 120 route des macarons, 60 560 Valbonne, France Telephone: Official Contact: Laurent Meilhac, Ph.D., CEO

#### REPRESENTATIVE/CONSULTANT

Allison C. Komiyama, Ph.D., R.A.C. Lucie Dalet, Ph.D. AcKnowledge Regulatory Strategies, LLC Telephone: [phone] Email: [e-mail]

# PROPRIETARY NAME OF SUBJECT DEVICE

Exciplex308nm

#### COMMON NAME

Light, Ultraviolet, Dermatological

#### DEVICE CLASSIFICATION

Ultraviolet lamp for dermatologic disorders (21 CFR 878.4630, FTC, Class II)

#### PREMARKET REVIEW

ODE/DSD/General Surgery Devices Branch One (GSDB1) General & Plastic Surgery

#### INDICATIONS FOR USE

The Exciplex3080mm is intended to be used for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.

#### DEVICE DESCRIPTION

The Exciplex 308m" is a compact handheld excimer device that emits a narrow-band UVB light at 308nm. This ultraviolet wavelength of light is known to be beneficial in the treatment of various dermatological conditions such as psoriasis and vitiligo. The UVB light is homogeneously

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows a logo for a company or brand named "Clarteis". The logo consists of two parts: a rounded square with a white circle inside, and the name "Clarteis" written in a cursive font. The logo is green.

delivered through a 5x5cm² output window at an irradiance of 100mW/cm². Treatments are performed by applying the output window over the affected area with the help of treatment tips or silicone masks to shield the surrounding healthy skin. A treatment might consist of a series of light "shots" where the device is used multiple times along the affected area.

## PREDICATE DEVICE IDENTIFICATION

The Exciplex3080mm is substantially equivalent to the following predicates:

| 510(k) Number | Predicate Device Name / Manufacturer | Primary Predicate |
|---------------|--------------------------------------------------------------------|-------------------|
| K073066 | Model 308 Dermatological Excimer System / Quantel<br>Medical, Inc. | ✓ |
| K150752 | GME ExSys 308 / GME German Medical Engineering GmbH | |
| K051428 | VTRAC Excimer Lamp System / PhotoMedex, Inc. | |

## SUMMARY OF NON-CLINICAL TESTING

No FDA performance standards have been established for the Exciplex 38000. The following tests were performed to demonstrate safety based on current industry standards:

Software Verification: The software development and testing was executed in compliance to IEC 60601-1, IEC 62304 and ISO 14971.

Electromagnetic Compatibility and Electrical Safety: The subject device was tested in compliance to IEC 60601-1, IEC60601-1-2 and IEC 60601-2-57.

Performance and usability testing: The subject device was tested in compliance to IEC 62471, IEC 62366-1 and IEC 60601-1-6.

The results of these tests indicate that the Exciplex3080™ is substantially equivalent to the predicate devices.

#### EQUIVALENCE TO PREDICATE DEVICES

Clarteis believes that the Exciplex 388m : is substantially equivalent to the predicate devices based on the information summarized here:

The subject device has a similar design and dimensions, and uses similar materials as the device cleared in K073066. The subject device has the same intended use and similar technological characteristics (light source, wavelength, treatment area size, fluence range) to the devices cleared in K073066, K150752, and K051428. Any differences in technological characteristics do not raise different questions of safety and effectiveness and performance data demonstrate substantial equivalence to the predicates.

{5}------------------------------------------------

Image /page/5/Picture/1 description: The image shows a logo with a green square with rounded corners and a white circle inside. To the right of the square is the word "Clarteis" written in a cursive font, also in green. The logo appears to be for a company or organization named Clarteis.

## CONCLUSION

Based on the testing performed, including irradiance uniformity, ability of the masks and tips to block UV light, classification of the UV lamp, and software and hardware verification testing, it can be concluded that the subject device does not raise new issues of safety or effectiveness compared to the predicate devices. The similar indications for use, technological characteristics, and performance characteristics for the proposed Exciplex380m" are assessed to be substantially equivalent to the predicate devices.